Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 3, 2022, after the close
10-Q filed Aug 8, 2022, 39 days after period end · 0001299130-22-000101
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $35.47M | $30.61M | $19.08M | $24.62M |
| Net Income | -$71.39M | -$41.00M | -$23.09M | -$24.60M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.32 |
| -$0.21 |
| -$0.15 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
